Onset Therapeutics LLC
Onset Therapeutics is a pharmaceutical company, engaged in the development of topical products for the wound care markets. The company is a wholly-owned subsidiary of Collegium Pharmaceutical. The company`s products are used in the treatment of skin disorders, wounds, decubitus ulcers, varicose ulcers, dehiscent wounds, genital warts and venereal diseases. Its products are developed using its patented drug delivery formulations. Its emollient foam is used in treating xerosis, ichthyosis, skin cracks and fissures, dermatitis, eczema, psoriasis, keratoses and calluses. Onset`s products are used by dermatologists in long term care facilities, wound care clinics and hospitals. The company is headquartered in Rhode Island, the US.
On October 2, 2009, the company launched BenzEFoam Emollient Foam indicated for topical treatment of mild to moderate acne vulgaris.